Cargando…
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes
The potential anticancer effects of statins—a widely used class of cholesterol lowering drugs—has generated significant interest, as has the use of epigenetic modifying drugs such as HDAC and DNMT inhibitors. We set out to investigate the effect of statin drugs on epigenetic modifications in multipl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521159/ https://www.ncbi.nlm.nih.gov/pubmed/30974899 http://dx.doi.org/10.3390/cancers11040516 |
_version_ | 1783418892514754560 |
---|---|
author | Bridgeman, Stephanie Northrop, Wendy Ellison, Gaewyn Sabapathy, Thiru Melton, Phillip E. Newsholme, Philip Mamotte, Cyril D. S. |
author_facet | Bridgeman, Stephanie Northrop, Wendy Ellison, Gaewyn Sabapathy, Thiru Melton, Phillip E. Newsholme, Philip Mamotte, Cyril D. S. |
author_sort | Bridgeman, Stephanie |
collection | PubMed |
description | The potential anticancer effects of statins—a widely used class of cholesterol lowering drugs—has generated significant interest, as has the use of epigenetic modifying drugs such as HDAC and DNMT inhibitors. We set out to investigate the effect of statin drugs on epigenetic modifications in multiple cell lines, including hepatocellular carcinoma, breast carcinoma, leukemic macrophages, cervical adenocarcinoma, and insulin-secreting cells, as well as liver extracts from statin-treated C57B1/6J mice. Cells or cell extracts were treated with statins and with established epigenetic modulators, and HDAC, HAT, and DNMT activities were quantified. We also examined histone acetylation by immunoblotting. Statins altered neither HDAC nor HAT activity. Accordingly, acetylation of histones H3 and H4 was unchanged with statin treatment. However, statins tended to increase DNMT activity. These results indicate that direct inhibition of the major classes of epigenetic modifying enzymes, as previously reported elsewhere, is unlikely to contribute to any anticancer effects of statins. This study concerned global effects on epigenetic enzyme activities and histone acetylation; whether statins influence epigenetic modifications in certain genomic regions, cannot be ruled out and remains to be investigated. |
format | Online Article Text |
id | pubmed-6521159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65211592019-05-31 Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes Bridgeman, Stephanie Northrop, Wendy Ellison, Gaewyn Sabapathy, Thiru Melton, Phillip E. Newsholme, Philip Mamotte, Cyril D. S. Cancers (Basel) Article The potential anticancer effects of statins—a widely used class of cholesterol lowering drugs—has generated significant interest, as has the use of epigenetic modifying drugs such as HDAC and DNMT inhibitors. We set out to investigate the effect of statin drugs on epigenetic modifications in multiple cell lines, including hepatocellular carcinoma, breast carcinoma, leukemic macrophages, cervical adenocarcinoma, and insulin-secreting cells, as well as liver extracts from statin-treated C57B1/6J mice. Cells or cell extracts were treated with statins and with established epigenetic modulators, and HDAC, HAT, and DNMT activities were quantified. We also examined histone acetylation by immunoblotting. Statins altered neither HDAC nor HAT activity. Accordingly, acetylation of histones H3 and H4 was unchanged with statin treatment. However, statins tended to increase DNMT activity. These results indicate that direct inhibition of the major classes of epigenetic modifying enzymes, as previously reported elsewhere, is unlikely to contribute to any anticancer effects of statins. This study concerned global effects on epigenetic enzyme activities and histone acetylation; whether statins influence epigenetic modifications in certain genomic regions, cannot be ruled out and remains to be investigated. MDPI 2019-04-10 /pmc/articles/PMC6521159/ /pubmed/30974899 http://dx.doi.org/10.3390/cancers11040516 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bridgeman, Stephanie Northrop, Wendy Ellison, Gaewyn Sabapathy, Thiru Melton, Phillip E. Newsholme, Philip Mamotte, Cyril D. S. Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title | Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title_full | Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title_fullStr | Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title_full_unstemmed | Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title_short | Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes |
title_sort | statins do not directly inhibit the activity of major epigenetic modifying enzymes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521159/ https://www.ncbi.nlm.nih.gov/pubmed/30974899 http://dx.doi.org/10.3390/cancers11040516 |
work_keys_str_mv | AT bridgemanstephanie statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT northropwendy statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT ellisongaewyn statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT sabapathythiru statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT meltonphillipe statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT newsholmephilip statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes AT mamottecyrilds statinsdonotdirectlyinhibittheactivityofmajorepigeneticmodifyingenzymes |